Breaking News
4 hours ago
Pharma Now Editorial Team

Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Kyowa Kirin secures public reimbursement for burosumab in four Canadian provinces and the federal NIHB program, closing a coverage gap for adults with XLH.
Pharma Now Editorial Team

Cristcot appoints Rayna Herman to lead its HCA commercial division as the company's ngHCA suppository remains under FDA review.
Pharma Now Editorial Team

Parexel acquires Vitrana to integrate AI-powered pharmacovigilance, reshaping safety reporting workflows for drug manufacturers and CRO partners.
Pharma Now Editorial Team

FDA converts selpercatinib to traditional approval for RET-mutant MTC, with LIBRETTO-531 PFS data satisfying confirmatory evidence requirements.
Pharma Now Editorial Team
